ici 204,219 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conklyn, M; Showell, HJ; Watson, JW | 1 |
Barnes, PJ; Chung, KF; Kidney, JC; Ridge, SM | 1 |
1 trial(s) available for ici 204,219 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
Topics: Adult; Airway Resistance; Bronchoconstriction; Double-Blind Method; Humans; Indoles; Leukocyte Count; Male; Neutrophils; Phenylcarbamates; Platelet Activating Factor; SRS-A; Sulfonamides; Tosyl Compounds | 1993 |
1 other study(ies) available for ici 204,219 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators.
Topics: Acute Disease; Animals; Azepines; Bronchoconstriction; Dicarboxylic Acids; Dose-Response Relationship, Drug; Furans; Guinea Pigs; Immunization; Immunoglobulin G; Indoles; Lipids; Lung; Male; Ovalbumin; Phenylcarbamates; Piroxicam; Platelet Activating Factor; Propranolol; Pyrilamine; Respiratory Hypersensitivity; SRS-A; Sulfonamides; Tosyl Compounds; Triazoles | 1990 |